More stories

  • in

    GM lays off more than 1,700 at sites in Michigan, Ohio, citing EV challenges

    General Motors laid off more than 1,700 workers across manufacturing sites in Michigan and Ohio, the company confirmed to CNBC.
    The layoffs include jobs at Detroit’s electric vehicle plant and Ohio’s Ultium Cells battery cell plant, in addition to temporary layoffs at Ultium Cells’ Tennessee plant.
    The company cited a slowdown in the electric vehicle market.

    The Ultium Cell factory in Warren, Ohio, is shown, July 7, 2023.
    Gene J. Puskar | AP

    General Motors laid off roughly 1,700 workers at manufacturing sites in Michigan and Ohio on Wednesday, citing a slowdown in the electric vehicle market.
    The company confirmed there were around 1,200 layoffs at Detroit’s electric vehicle plant and 550 cuts at Ohio’s Ultium Cells battery cell plant, in addition to 850 temporary layoffs at that site in Ohio. The company also said it would temporarily lay off 700 at Ultium Cells’ Tennessee plant.

    “In response to slower near-term EV adoption and an evolving regulatory environment, General Motors is realigning EV capacity,” the company said in a statement. “Despite these changes, GM remains committed to our U.S. manufacturing footprint, and we believe our investments and dedication to flexible operations will make GM more resilient and capable of leading through change.”
    GM also said battery cell production at its Ohio and Tennessee facilities will be temporarily paused beginning in January. It anticipates resuming operations at both battery cell sites by the middle of 2026 and will use the pause to upgrade its facilities.
    Wednesday’s layoffs follow the company saying last week that it would cut more than 200 salaried employees, mostly engineers at its global tech campus in metro Detroit, as part of a restructuring effort.
    After September, federal incentives of up to $7,500 to purchase electric vehicles was discontinued, leaving consumers racing to use the benefit before the expiration. Though sales for plug-in vehicles soared to records for many automakers in the third quarter, that demand is expected to decline following the discontinuation.
    GM previously reported a more than doubling of sales for electric vehicles during the third quarter from the year prior, a trend other automakers like Ford Motor and Hyundai saw as well.

    “We continue to believe that there is a strong future for electric vehicles, and we’ve got a great portfolio to be competitive, but we do have some structural changes that we need to do to make sure that we lower the cost of producing those vehicles,” CFO Paul Jacobson told CNBC’s Phil LeBeau during “Squawk Box” last week.
    Still, GM’s third-quarter results last week included a $1.6 billion impact from its all-electric vehicle plans not playing out as anticipated, signaling it was undergoing a reassessment of its EV capacity and manufacturing processes.
    The Detroit News first reported on the layoffs. More

  • in

    Boeing stems cash burn for first time since 2023 but takes $4.9 billion charge on 777X delays

    Boeing reported higher revenue than last year when production was constrained after a safety crisis and amid a labor strike.
    Boeing is on track for its highest airplane deliveries since 2018.
    CEO Kelly Ortberg, who took the reins in August 2024, was tasked with improving quality, reliability and safety at Boeing.

    A Boeing 777x is displayed during the International Paris Air Show at the Paris-Le Bourget Airport on June 20, 2023.
    Geoffroy Van Der Hasselt | AFP | Getty Images

    Boeing said Wednesday its jetliner deliveries drove it back into cash-positive territory for the first time in nearly two years, but it took a $4.9 billion charge on additional delays of its long-awaited 777X wide-body plane.
    Boeing is on track to deliver the most aircraft this year since 2018, before two crashes grounded its bestselling jetliner, the Covid pandemic hit supply chains and a host of manufacturing crises drove years of losses at the top U.S. exporter.

    CEO Kelly Ortberg, an aerospace veteran who came out of retirement to helm Boeing in August 2024, has worked to steady the manufacturer’s sprawling supply chain and cash-generating production lines.
    The 777X, an updated version of its 777 plane, took its first flight nearly six years ago but still hasn’t won regulator approval. Boeing says it now expects the first delivery in 2027, leading to the noncash charge.

    A Boeing 777x aircraft during an aerial display on the opening day of the Farnborough International Airshow in Farnborough, UK, on Monday, July 18, 2022.
    Jason Alden | Bloomberg | Getty Images

    “While there’s still more work to do to advance our development programs, particularly on our commercial development and certification programs, we’re seeing positive signs across our business, and I’m proud of how we are coming together to turn our company around,” Ortberg said in a staff note.
    Still, Boeing generated free cash flow of $238 million, its first time in the black on that metric since late 2023.
    Boeing lost $4.78 billion, or $7.14 a share, in the three months ended Sept. 30. That’s better than a $5.76 billion loss a year earlier. On an adjusted basis, the company reported a loss of $7.47 a share. Revenue jumped 30% to $23.27 billion for the third quarter, up from $17.84 billion a year ago and ahead of analysts’ estimates.

    A year ago, Boeing machinists were on strike in a contract impasse that crippled production at the majority of the company’s commercial airplane factories.
    Here’s how Boeing performed for the third quarter compared with analysts’ estimates compiled by LSEG:

    Loss per share: $7.47 per share adjusted vs. a loss of $4.59 expected
    Revenue: $23.27 billion vs. $21.97 billion expected

    Airline customers have said they’ve seen an improvement at Boeing, with more accurate delivery projections, a change in tune from the complaints of prior years.
    In the first nine months of the year, Boeing delivered 440 airplanes, up from 291 in the same period last year. Airlines and other customers pay for the bulk of the planes when they receive them, so increasing the delivery pace is key for Boeing to stem an outflow of cash totaling close to $17 billion since the start of 2024 through June of this year.

    Read more CNBC airline news

    Last year was supposed to be a turnaround year for Boeing, but a midair blowout of a door panel in January 2024 resulted in a near catastrophe and increased federal scrutiny that slowed production.
    But Boeing has made progress. Earlier this month, the Federal Aviation Administration lifted a production cap for Boeing’s 737 Max to 42 a month from 38, a restriction it put in place after the accident.
    The FAA is also now allowing Boeing to perform final sign-offs on some of its aircraft, a sign of increased confidence from its regulator.
    Boeing’s commercial unit revenue rose 49% from a year earlier to $11.09 billion, though it still had negative operating margins. Its defense unit generated $6.9 billion, up 25% from last year in the third quarter, with a 1.7% operating margin, while its profitable global services business brought in nearly $5.4 billion, a 10% increase.
    The company isn’t out of the woods. Its Max 7 and Max 10 variants and the 777X are years behind schedule.
    And about 3,200 of its defense unit workers who make F-15 fighter jets and missile systems have been on strike since the summer as the two sides have yet to reach a new contract. More

  • in

    Biotech beauty company Debut brings new ingredients, products to skincare market

    Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned.
    The San Diego-based company uses biotechnology and artificial intelligence to identify, cultivate, copy and scale ingredients that occur naturally into formulations for skincare.
    Experts say biotechnology is shaping up to be the future of the beauty industry at large — and that brands like Sephora and Ulta will need to take notice.

    A Debut Biotech petri dish.
    Courtesy: Debut Biotech

    In a lab tucked away in southern California, scientists at Debut Biotech are testing molecules using advanced biotechnology to create new skincare formulations.
    The San Diego-based company, founded nearly seven years ago, is pioneering new ingredients to specially target various aspects of skin health. One of the company’s latest innovations, an ingredient named EDL, will be used in a new skin-tightening product with Image Skincare scheduled to hit the shelves next year, CNBC has learned.

    “The reason why we exist is we do believe that biology can make better things and it can deliver sustainable performance alternatives to what’s currently available for the world,” CEO Joshua Britton told CNBC.
    The company focuses on identifying and copying molecules found in nature, refining and scaling those ingredients for their specific skin longevity benefits, and formulating them into products that satisfy consumer needs. Britton defined biotechnology as the use of advanced tech to “discover, validate and commercialize higher performing ingredients.” 
    But Debut’s “secret sauce,” he added, is the company’s vertically integrated company structure, which ensures it can perform its research and development and also see its products into the supply chain, all in-house.
    “Like pharmaceutical companies, they own their manufacturing processes, they own the making of the product, they own the marketing around the product and they sell directly to doctors,” Britton said. “And so the synthetic biology industry had to learn that, overcome those issues, but now it’s taken off, and we’re seeing real change.”
    Debut then works with its slate of clients, from beauty giant L’Oreal to smaller brands like Reome, to incorporate its ingredients into products and formulations.

    Because of its vertical integration structure, Debut is able to speed up its process, Britton said, with iteration cycles taking just one to two weeks, allowing the company to ensure its discoveries make it directly into the hands of consumers.
    “The investor base on the private and public side has always seen the promise of biotechnology but have always invested into companies who are horizontal and have unfortunately lost a lot of money,” Britton said. “But now the investors are starting to see things turn up in the supermarket, in the local market, in supply chains — we’re about to see this resurgence of biotechnology, and the resurgence this time will have a product focus, not a science focus.”
    That structure is becoming increasingly important for beauty brands, according to Lindy Firstenberg, AlixPartners’ senior vice president of beauty and luxury. The consumer base is becoming more educated about the products they’re putting on their skin, with the rise of what Firstenberg calls the “consumer Ph.D.” 
    With the more knowledgeable customer, she said, comes a greater demand for hard science typically seen in the pharmaceutical sector. 
    “Because of that, you’ve seen this rise of vertical integration, and what it’s really doing is it’s delivering for the customer what they’re really asking for,” she told CNBC. “Because these consumers are asking for holistic programs, they’re thinking about infusions, injectables, ingestibles, topicals, tool therapy; they’re really looking for absolutely everything.”
    In a world in which beauty and wellness have become deeply ingrained and intertwined with everyday routines, Firstenberg said she believes biotechnology in the industry is not just a fad and instead here to stay.
    “I actually do think that you’ll end up having these beauty, health and wellness companies that are integrated, and they have different delivery methodologies and different delivery systems, because you’re going to have fewer beauty, health and wellness companies that can actually do it,” Firstenberg said. “The ones that can do it are really, really going to set themselves apart.”

    Inside a lab at Debut Biotech with CEO Joshua Britton.
    Courtesy: Debut Biotech

    New innovations

    Some of Debut’s ingredients are already on the market. Earlier this year, it partnered with Reome to introduce an ingredient named DHK, targeting skin barrier repair and derived from the Joshua Tree cactus in the desert.
    Reome founder Joanna Ellner said using natural ingredients alone often produces inconsistent results based on varying harvests and can harm the environment, but biotech allows Reome to use those components in a more sustainable and consistent way.
    “Based on the delivery system of biotech ingredients, we have the power to hit new levels of efficacy within skincare that have never been possible before,” Ellner told CNBC. 
    The company’s eye cream, featuring Debut’s DHK molecule, focuses on firming the skin around the eyes, and Ellner said it is 1.3 times more effective than standard ingredients like vitamin C. 
    “For me, the thrill is we are genuinely working with new ingredients, and we are generally at the very sharp end of innovation,” Ellner said. “We are not combining a bunch of pre-existing ingredients together and calling it a new word or some kind of compound — this is real.”
    The new collaboration with Image Skincare features Debut’s EDL ingredient, which focuses on the viral topic of skin tightening. The company, which most recently developed a topical product to firm skin for GLP-1 patients experiencing rapid weight loss, aims to be at the forefront of innovation and new trends, according to CEO Sennen Pamich.
    The new partnership with Debut aligned with just that, he added.
    In initial clinical trials, Pamich said the company has seen the product’s ability to enhance skin longevity and vitality when combined with Image’s pre-existing formulations, including its technology that allows antioxidants to deeply penetrate the skin.
    “There is a very high level of application of biotech in the pharmaceutical world, right? So why not in skincare and beauty?” Pamich said. 

    Future of biotech

    Debut is still in the lab developing more biotech ingredients to target specific consumer concerns, like its new PNAR ingredient, which helps with hyperpigmentation. 
    While that process could take other companies close to two decades, the use of artificial intelligence and biotech to arrive at these ingredients allows Debut’s process to take just around a year, Britton added.
    And that speed, efficiency and accuracy is why he believes biotech is the future of innovation, not just in beauty. While Debut chose the beauty sector specifically for its higher margins, Britton said he can see vertical integration and biotech being useful in a variety of other industries, like nutrition.

    A lab at Debut Biotech.
    Courtesy: Debut Biotech

    That sentiment was echoed by Oliver Wright, Accenture’s global consumer industries lead, who emphasized that the technology’s ability to create targeted molecules while prioritizing sustainability will allow it to flourish.
    According to research from Accenture, demand for bioengineered ingredients is expected to grow 15% to 20% annually through 2026, driven by Gen Z’s trust in science-backed solutions. The market for biotech skincare is expected to surpass $8 billion by 2031, according to Precision Business Insights.
    “Biotech is about enhancing nature’s products – yes, it takes place in labs, but it is fundamentally about taking a human product that exists in nature and actually making sure that you refine that and create it for human benefit,” Wright told CNBC. “So people don’t need to be scared of it in the way that they might do otherwise.”
    In other words, this new technology is moving the needle — and beauty giants like Sephora and Ulta will need to take notice and shape their messaging for consumers who may be overwhelmed by the plethora of options, Wright said. 
    Still, the next step is toward the “holy grail of cosmetics,” he said: personalized beauty. With the advent of generative AI and consumers’ growing knowledge of science and technology, Wright said he expects there to be a broadening of the definition of beauty to encapsulate wellness. 
    “I think the destination here is going to be the increasing ability for us to tailor this through diagnostics, through, therefore, product selection, but then increasingly towards actual personalization,” Wright said. “I think in effect, if we fast forward 10 years, that will be the normal in the industry.” More

  • in

    Why global investment firm Nuveen is betting on this niche real estate subsector

    Chad Phillips, global head of Nuveen Real Estate, says grocery-anchored, open-air strip centers present big opportunity.
    Vacancy rates in these spaces were 7.8% at the start of 2016, but came down to 4.4% by the beginning of this year, according to data from CoStar Group.
    Phillips said he likes this smaller sector because they’re “bite-sized deals” and they strip centers are often in the customer’s path of convenience.

    An open-air strip retail center in Richmond, Virginia.
    Courtesy of Nuveen

    A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox.
    It would be an understatement to say that retail real estate has had a rough ride. It started with the birth of e-commerce and escalated with the Covid-19 pandemic. Its recovery has been splintered, given the varying subsectors of retail, from large indoor malls to big-box centers to grocery-anchored, open-air strip centers.

    It’s that last subsector that Chad Phillips, global head of Nuveen Real Estate and responsible for over $140 billion of commercial real estate equity and debt investments, says is the big opportunity today. 
    “We’ve leaned into this resilient, open-air strategy the last two years pretty heavily,” said Phillips. 
    That’s grocery-anchored centers with, perhaps, a CVS and a pizza place and the like. Vacancy rates in these spaces were 7.8% at the start of 2016, but came down to 4.4% by the beginning of this year, according to data from CoStar Group.
    “It survived Covid. It survived the Amazon effect,” Phillips said. “The occupancies within our grocery-anchored, open-air portfolio in good locations is over 95% leased.”
    Whenever a tenant closes its doors, Nuveen is able to refill the spot quickly due to such strong demand, Phillips said. 

    He admitted that retail real estate had been overbuilt for a long time in the U.S. Eventually, developers became more disciplined, especially with the birth of e-commerce. That resulted in a correction that created something of an undersupply today. 
    “The [capitalization] rates that you can buy them at are fairly attractive,” said Phillips. “So the total returns are good. You’re buying at far less than replacement cost. So you put it all together, and it’s a very resilient, essential real estate need where we can make strong, risk-adjusted returns.”
    While larger, indoor mall traffic is rising, especially in the highest-end malls, Phillips said he likes this smaller sector because they’re “bite-sized deals.” You can sell them easily. They’re liquid. Malls are not. 
    It’s also a factor of simple supply and demand. Roughly 15 years ago, allocations to retail were over 30% for real estate investors, but that dropped to 10% because the returns were weak, according to Nuveen. Now, in just the last 12 months, the returns are improving, and investors are looking again. 
    “I wouldn’t say they’re flooding back, but we’ve raised year-to-date [for] convenience-based retail $1.4 billion of equity with leverage,” Phillips said. “That puts us over $2.5 billion of buying power for these types of strategies. So yeah, I do think that investors are turning their heads.” 

    Get Property Play directly to your inbox

    CNBC’s Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox.
    Subscribe here to get access today.

    This is not to say that the sector, like any other, is not without risk. After a few years of outperformance, it’s starting to slow down.
    “After five years of consistent demand and rent growth, fundamentals are softening,” wrote Brandon Svec, national director of U.S. retail analytics at CoStar Group in a recent company newsletter, noting vacancy rates in grocery-anchored, open-air spaces have ticked up for three consecutive quarters. (Though they’re still near historic lows.)
    But Svec added that the broader retail leasing environment tells a different story.
    “With little new retail space expected to be added over the next few years, and availability conditions sitting near historically tight levels, retailers are staying active in their pursuit of new locations,” Svec said. 
    He also said there’s concern about the state of the overall economy, consumer confidence and consumer spending. 
    After strong rent growth in previous years for the grocery-anchored, open-air subsector, it has stalled this year, with annual rent growth the weakest in more than a decade. This is a clear departure from prior years, Svec emphasized.
    Phillips said that’s why the strategy requires that investors be particularly picky about the properties. 
    Consumer confidence ebbs and flows, and that has an impact on whether they’re going to go to these centers for coffee or to get a manicure. The existing customer base, namely those with higher savings rates who can withstand higher unemployment, are vital to choosing where to invest. 
    Phillips said an average household income of over $100,000 and a largely millennial, well-educated population are among the criteria he looks for. 
    Competition among investors is rising, but not to the point where good deals can’t get done, he said, citing low, double-digit returns. 
    He added low levels of new construction are helping to keep vacancies down, and the spaces draw consistent crowds.
    “I do think it’s a lot about convenience and being in the path of that convenience, and that’s where we want to invest,” said Phillips. More

  • in

    CVS beats estimates, hikes guidance as insurance business improves

    CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit.
    The quarterly results cap David Joyner’s first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.
    Joyner highlighted recovery in Aetna, the company’s insurer, a “really good sales season” for the company’s pharmacy benefit manager, Caremark, and a $5.7 billion goodwill impairment charge related to the health care delivery reporting unit.

    Signage for a CVS pharmacy in Takoma Park, Maryland, US, on Wednesday, July 9, 2025.
    Al Drago | Bloomberg | Getty Images

    CVS Health on Wednesday reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit.
    Still, shares of CVS fell more than 3% in premarket trading Wednesday as the company posted a net loss during the quarter, which reflects a $5.7 billion goodwill impairment charge related to the health care services segment’s health care delivery reporting unit.

    The quarterly results cap David Joyner’s first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under its last top executive, Karen Lynch. Joyner is executing aggressive efforts to turn the flailing drugstore chain around – from executive reshuffling to cost cuts – and they already seem to be paying off, with shares up more than 85% for the year.
    The company now expects fiscal 2025 adjusted earnings of $6.55 to $6.65 per share, up from previous guidance of $6.30 to $6.40 per share. CVS has now hiked its outlook for three consecutive quarters.
    “[I] couldn’t be more happy about the fact that this is three quarters where we’ve had a beat and raise and obviously, looking into Q4, we feel really, really good about our ability to close out the year favorably,” Joyner said in an interview. 
    He pointed to several factors, including recovery in Aetna, the company’s insurer. Aetna and other insurers have grappled with higher-than-expected medical costs over the last year as more Medicare Advantage patients return to hospitals for procedures they delayed during the pandemic. While medical costs remain high, Aetna and other insurers, such as UnitedHealthcare, appear to be becoming better equipped to navigate the issue moving forward.
    Joyner also highlighted a “really good sales season” for its pharmacy benefit manager, Caremark, and the goodwill impairment charge related to the health care delivery reporting unit.

    Here’s what CVS reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: 

    Earnings per share: $1.60 adjusted vs. $1.37 expected
    Revenue: $102.87 billion vs. $98.85 billion expected

    The company posted net loss of $3.99 billion, or $3.13 per share, for the third quarter. That compares with net income of $71 million, or 7 cents per share, for the same period a year ago. 
    In a release, CVS said the loss reflects the goodwill impairment charge related to the health care delivery reporting unit, which has “continued to experience challenges which have impacted its ability to grow the business at the rate previously estimated.” The company made several changes to that segment’s management team and finalized strategic changes, including plans to reduce the number of primary care clinics it would open in 2026 and beyond. 
    “We’ve effectively made the decision this quarter to both slow the clinic growth and also close some of the underperforming clinics,” Joyner said. He noted that CVS has announced that it will close 16 locations of primary care provider Oak Street Health. 
    But Joyner said “this does not change our views of value-based care,” noting that Oak Street Health is “actually performing according to plan.” 
    Excluding certain items, such as amortization of intangible assets, restructuring charges and capital losses, adjusted earnings were $1.60 per share for the quarter.
    CVS booked sales of $102.87 billion for the third quarter, up 7.8% from the same period a year ago as all three of its business segments grew. Wall Street didn’t expect CVS to reach quarterly sales of more than $100 billion until the fourth quarter, according to StreetAccount estimates. 

    Growth across business units

    All three of CVS’ business units beat Wall Street’s revenue expectations for the third quarter, with notable improvements in the insurance business. 
    The insurance segment’s medical benefit ratio – a measure of total medical expenses paid relative to premiums collected – decreased to 92.8% from 95.2 % a year earlier. A lower ratio typically indicates that a company collected more in premiums than it paid out in benefits, resulting in higher profitability.
    That ratio is slightly higher than the 92.4% that analysts had expected, according to StreetAccount.
    CVS said that was driven by the “favorable year-over-year impact of premium deficiency reserves recorded as health care costs” and improved underlying performance in the insurance unit’s government business, among other factors. Premium deficiency reserves refers to a liability that an insurer may need to cover if future premiums are not enough to pay for anticipated claims and expenses.
    Aetna’s government business serves plans including Medicare Advantage and Medicare prescription drug, or Part D, plans.
    The insurance business booked $35.99 billion in revenue during the quarter, up more than 9% from the third quarter of 2024. Analysts expected the unit to take in $34.48 billion for the period, according to estimates from StreetAccount.
    CVS said that growth was driven by increases in the government business, largely due to the impact of the Inflation Reduction Act on the Medicare Part D program. Provisions of that law have contributed to increases in some Medicare Part D premiums.
    CVS’ pharmacy and consumer wellness division posted $36.21 billion in sales for the third quarter, up 11.7% from the same period a year earlier.
    CVS said the increase came partly from higher prescription volume, including from the company’s acquisition of prescriptions from Rite Aid, but offset by pharmacy reimbursement pressure. Analysts expected sales of $35.6 billion for the quarter, StreetAccount said.
    That unit dispenses prescriptions in CVS’ more than 9,000 retail pharmacies and provides other pharmacy services, such as vaccinations and diagnostic testing.
    CVS’ health services segment generated $49.27 billion in revenue for the quarter, up 11.6% compared with the same quarter in 2024. Analysts expected the unit to post $45.71 billion in sales for the period, according to StreetAccount.
    That unit includes Caremark, which negotiates drug discounts with manufacturers on behalf of insurance plans and creates lists of medications, or formularies, that are covered by insurance and reimburses pharmacies for prescriptions.
    — CNBC’s Bertha Coombs contributed to this report More

  • in

    ‘We’re trying to shame them’: Upstart activist investors target America’s underperforming banks

    Hedge fund HoldCo has emerged from relative obscurity to launch activist investor campaigns against three regional banks: Comerica, Eastern Bank and First Interstate.
    Founders Vik Ghei and Misha Zaitzeff tell CNBC exclusively about their next two targets, Columbia Bank and Bank United, and their broader plans to challenge banking CEOs.
    The millennial upstarts are bringing activism back to a sector that had been largely immune to it since the 2008 financial crisis. It comes amid a wave of regional bank consolidation.
    On Tuesday, after publication of this story, Columbia Bank rose 4.4%, the biggest gainer of the more than 140 banks in the S&P Regional Banking ETF. BankUnited climbed 2.1%.

    Misha Zaitzeff and Vik Ghei, founders of HoldCo Asset Management, at their Fort Lauderdale, Florida, offices.
    Courtesy: HoldCo

    American banks have found an unlikely pair of adversaries in Vik Ghei and Misha Zaitzeff.
    Since July, the nine-person hedge fund they run from Fort Lauderdale, Florida, called HoldCo, has challenged lenders with more than $200 billion in combined assets, demanding that they take swift action or face public campaigns to overthrow their boards and fire their CEOs.

    The fund notched a victory this month after Comerica, under pressure from HoldCo, agreed to sell itself to rival Fifth Third for $10.9 billion in the biggest bank merger of the year. HoldCo has since announced activist campaigns against two smaller regional lenders, Boston-based Eastern Bank and Billings, Montana-based First Interstate.
    A fourth bank is now in their sights, CNBC has learned exclusively: HoldCo plans to launch a proxy battle against Columbia Bank, a lender with $70 billion in assets and 350 branches across Western states, unless it can strike a deal with management.
    HoldCo, with $2.6 billion in assets, is bringing back activism to an industry that has largely been insulated from it since the 2008 financial crisis. The demise of bank-specific hedge funds in the post-crisis years and regulatory resistance to mergers meant that underperforming CEOs faced little discipline from the markets until now, according to Ghei and Zaitzeff.
    Regional banks have struggled to regain their footing after the 2023 crisis that consumed Silicon Valley Bank and First Republic, leaving them exposed to activists seeking undervalued targets. At the same time, mergers are now viewed as more likely to be approved by regulators in the Trump administration, giving activists like HoldCo a clear exit strategy.
    Coming from a hedge fund that few outside of banking circles had heard of, HoldCo’s moves have garnered admiration in some corners of Wall Street, while making them a pariah in others.

    Ghei and Zaitzeff say HoldCo has been banned from attending a banking conference held next month outside Miami by Piper Sandler, an investment bank known for advising regionals on mergers. A spokesman for Piper Sandler didn’t have a comment.
    The millennial upstarts now find themselves key players in a larger story of industry consolidation. While retail banking is dominated by three giants, JPMorgan Chase, Bank of America and Wells Fargo, the country has more than 4,400 banks, and a long-expected merger wave began this year.

    Bad incentives

    The HoldCo thesis on regional banks is simple: Many are undervalued because their CEOs have put their own interests above that of shareholders, Ghei and Zaitzeff told CNBC in interviews over the past month.
    That’s because the CEOs earn millions of dollars more in annual compensation if they grow by acquiring other banks, even if the deals prove disastrous for shareholders, according to the investors. Bank boards mostly operate as rubber stamps for such deals, they say, because directors are often handpicked by the CEOs themselves.
    “We’re trying to shame them into doing the right thing,” Ghei, 43, told CNBC. “At some of the banks we own, the CEOs have doubled compensation while their stocks have dramatically underperformed, or even fallen.”
    On top of that, some of the investment bankers and research analysts that cater to small and medium banks are complicit, because their firms earn fees from mergers, and shareholders are usually silent because they risk losing management access if they challenge bank leaders, said the HoldCo founders.
    “We feel that the way to rectify this is to publicly shame banks and aggressively pursue things like proxy battles,” Ghei said. “CEOs should be fired, and the boards should be fired, because they rolled the dice and lost; there should be consequences.”
    Regional banks face pressure to bulk up through mergers to compete with super regionals and megabanks, which have far larger budgets for technology and compliance, according to industry consultants who requested anonymity to speak candidly. Poorly managed firms are more the exception than the rule, they said.

    As a group, regional banks have trailed both larger peers and broader stock indexes in recent years, partly because of the hangover from the 2023 tumult. The S&P Regional Banking ETF is still 14% below its 2021 peak, and shares of regional lenders tumbled again this month on concern over a trio of defaults tied to alleged corporate fraud.
    In April, after bank stocks plunged in the sell-off sparked by President Donald Trump’s so-called liberation day tariff policies, HoldCo began loading up on shares of beaten-up regionals, including Columbia, Citizens Financial and KeyCorp.
    Those bets kick-started their recent round of activism and raised their profile: HoldCo “is quickly becoming a household name in both the regional banking space and the world of activism,” Gordon Haskett analyst Don Bilson wrote in an Oct. 21 research note.
    The firm’s rise has rattled executives across the U.S. regional banking landscape; several banks have quietly started reviewing their capital plans in anticipation of possible activist scrutiny, according to the industry advisors who spoke to CNBC.
    HoldCo said it now owns more than $1 billion in regional bank shares.

    ‘Best job in the world’

    Over steak dinners, Zoom meetings and phone calls, Ghei and Zaitzeff began private discussions with a succession of bank CEOs in recent months, hoping to persuade them to commit to their shareholder-friendly actions.
    When that approach has failed, they’ve gone public, releasing their presentations online and in the pages of The Wall Street Journal and Bloomberg News.
    It’s a playbook more familiar to other sectors including technology, media and health care, where hedge funds far larger than HoldCo have attempted to sway management with public campaigns.
    “I wish I could say there’s more nuance involved,” Ghei said. “But you actually need to put the CEO’s job at risk and make this very legitimate case that you can defeat them.”
    HoldCo’s campaign against Columbia Bank is one of the firm’s largest bets yet. Its position is worth roughly $150 million and makes up about 1.9% of the company’s voting shares.
    In a 71-page presentation, the activist said that while CEO Clint Stein quadrupled Columbia Bank’s assets through two acquisitions since taking over in 2020, the bank’s shares have fallen 36% during his tenure.
    At the same time, Stein’s most recent pay package rose 80% to $6.3 million from his 2021 compensation, the year he began announcing the takeovers.
    Columbia Bank declined to comment for this article.

    “Being a bank CEO is the best job in the world,” Ghei said. “You have incredible job security because shareholders never show their face and the board feels like they work for you. Everyone’s happy to meet you, and you have a bunch of investment bankers who want to make fees off of you.”
    Stein and his chief operating officer flew to Fort Lauderdale in August to meet the activists at a steakhouse two blocks from HoldCo’s offices on bustling Las Olas Boulevard, according to Ghei and Zaitzeff.
    Their meal was amicable enough, but the tone changed afterward when it became clear that HoldCo would pursue a proxy battle unless a deal was struck, meaning they would aim to replace directors with their own picks, with the ultimate goal of replacing Stein, according to the HoldCo duo.
    In late September, the HoldCo founders delivered their presentation to board members, slide by slide, over a Zoom call.
    HoldCo wants Columbia to swear off from doing more acquisitions, instead using excess cash to buy back their own cheap stock for five years, after which they should explore selling themselves to a larger bank.
    “They are honestly accomplished people, but not in banking,” Ghei said of the Columbia directors. “I don’t think they understood how bad the transactions they did were.”

    ‘Don’t take it personally’

    The HoldCo partners said they developed their appetite for confrontation in the rough-and-tumble world of distressed debt.
    Ghei, a former Goldman Sachs analyst covering financial firms, had figured out a way to make money picking through the remains of banks that had collapsed in the 2008 financial crisis.
    Then an analyst at Owl Creek, a hedge fund that specialized in the debt of failed companies, Ghei realized that bonds from the parent company of Washington Mutual were trading at deep discounts because everybody assumed that they wouldn’t be repaid.
    But they were ultimately repaid at full price, plus interest, making hundreds of millions of dollars for Owl Creek, according to an American Banker profile of Ghei from 2013.
    Ghei would repeat that trade at another Manhattan hedge fund, Tricadia, where he met Zaitzeff, a Brown University computer science graduate who ran models of new financial instruments called subprime collateralized debt obligations.
    Tricadia made millions by both creating subprime CDOs and then separately betting that other CDOs would fail, similar to trades from Goldman Sachs and others chronicled in the Michael Lewis book “The Big Short.”
    The men immediately hit it off, and in 2011 started their own firm out of “crummy offices” in New York’s Financial District, says Ghei. They called it HoldCo because of their early trades acquiring the debt of 70 holding companies whose banking subsidiaries had failed in the crisis.

    Ghei and Zaitzeff say they would spend most of their waking hours over the next 14 years together, angering their wives with their singular focus on batting around ideas for investments until they came to consensus.
    “We’re friends, first and foremost,” Zaitzeff, 42, said. “We spend a lot of time debating investments, but we don’t take it personally.”
    They believed the bonds of dead banks had value because of assets like tax refunds on corporate ledgers. But the Federal Deposit Insurance Corp., which took over the failed banks’ subsidiaries, believed it was entitled to the assets, not HoldCo.
    So HoldCo battled the FDIC in bankruptcy courts around the country, winning enough of the time on the strength of their arguments to develop a reputation as scrappy fighters.
    By 2013, the pair had raised their first institutional funds from an endowment; word of mouth then spread, and they eventually garnered investment from about 20 universities, hospitals and family offices in a series of ever-larger funds.

    One battle after another

    Their go-anywhere investment style led them to buy the distressed debt of a New Orleans-based lender named First NBC Bank in 2016; the bank had been established a decade earlier to help the city rebuild after Hurricane Katrina.
    After realizing that First NBC would soon be undercapitalized, HoldCo shorted the lender and published letters revealing their concerns. The bank’s auditor resigned and the institution was seized by the FDIC. In 2023, the former First NBC CEO Ashton Ryan was sentenced to 14 years in prison for bank fraud.
    It was experiences like that led Ghei and Zaitzeff to their dim view of bank management. By proving to themselves that they could identify situations where the market wasn’t functioning like it should, the HoldCo partners had the conviction to take on regional banks this year.

    First NBC Bank Chief Executive Ashton Ryan, center.
    Source: Nasdaq

    Banks didn’t understand the scope of HoldCo’s ambitions at first, the partners said.
    “People were surprisingly nice to us after Comerica,” Zaitzeff said. “When we went after Comerica, they viewed it as us going after a bigger bank. But a lot of regional banks view Eastern and First Interstate as much more like them.”
    Bank CEOs may believe that if they don’t engage with HoldCo, they can avoid activist campaigns, Zaitzeff said. The activists believe that’s why they were blacklisted from a recent banking conference.
    But the hedge fund has purchased almost 5% of the shares of BankUnited, a Miami Lakes, Florida-based lender with $35.5 billion in assets, without speaking to management, according to the pair.
    HoldCo plans to wage a proxy battle unless they can come to an agreement with management over increasing shareholder returns. BankUnited didn’t immediately return messages seeking comment.
    On Tuesday, after publication of this story, Columbia Bank rose 4.4%, the biggest gainer of the more than 140 banks in the S&P Regional Banking ETF. BankUnited climbed 2.1%.
    The investors, convinced of the righteousness of their position, say they also plan to publish regular dispatches about banks destroying shareholder value, even when they don’t hold a stake in the firm.
    “The problem is that for so many years there’s been no accountability, and the world has gone insane,” Ghei said. “We’re trying to call out bad decisions and incent them into doing the right thing.”
    — CNBC’s Gabriel Cortes contributed to this report. More

  • in

    Lucid targets industry-first self-driving car technology with Nvidia

    Lucid Group is targeting being the first automaker to offer highly advanced self-driving capabilities in its vehicles in the coming years.
    The all-electric vehicle manufacturer expects to launch what it’s calling “mind-off” driving in which a car can essentially drive itself under normal circumstances.
    Marc Winterhoff, interim CEO of Lucid, said the plan is to launch the new system “definitely in the coming years,” but he declined to specify an exact timeframe.

    The Lucid display is seen at the New York International Auto Show on April 16, 2025.
    Danielle DeVries | CNBC

    Lucid Group is targeting a new goal that would make it the first automaker to offer highly advanced self-driving capabilities in its vehicles in the coming years, the company said Tuesday.
    The all-electric vehicle manufacturer expects to launch what it’s calling “mind-off” driving in which a car can essentially drive itself under normal circumstances without a human needing to monitor it or intervene unless there’s a change in circumstances, such as severe weather. That would be like an occupant playing a game of cards or watching TV while the car is driving.

    Lucid on Tuesday said it plans to leverage Nvidia’s “Drive AV” platform and multisensor suite that includes cameras, radar, and lidar — or light detection and sensing, which allows the vehicle to better “see” its surroundings — for the forthcoming system.
    Marc Winterhoff, interim CEO of Lucid, said the plan is to debut the new system “definitely in the coming years,” but he declined to specify an exact timeframe other than it won’t be in 2026. The system is first planned for Lucid’s upcoming midsize vehicle before it would expand to other models, he said.
    “I want to make sure that we can offer this for our customers in a timeframe that I think is very ambitious, but at the same time, also we’re realistic,” Winterhoff told CNBC. “The main reason why I decided to not start from scratch, just do it ourselves, it’s simply time to market. … Also, it would cost a lot of money.”
    Winterhoff said Nvidia’s technologies will be a catalyst for the system, while Lucid plans to actually execute the self-driving technology.
    In the meantime, Winterhoff said Lucid plans to continue to increase the automated technologies on its current vehicles — the Air sedan and Gravity SUV — in partnership with Nvidia.

    A Lucid-supplied teaser image of its upcoming midsize vehicle behind its current Gravity SUV.

    “It will be a stepping stone,” said Winterhoff, who has served as interim CEO since company founder Peter Rawlinson left as chief executive in February.
    Many companies, including General Motors and Tesla, have promised personal self-driving vehicles but have failed to deliver. Automakers have invested billions of dollars working on autonomous vehicles in recent years, with most pulling back spending after years of trying to deploy the technologies.
    What Lucid is aiming to launch is what the industry refers to as “Level 4: High Driving Automation.” As defined by SAE International, formerly the Society of Automotive Engineers, Level 4 technologies should not require monitoring or human intervention under certain, but not all, conditions.
    There are a limited number of Level 4 vehicles currently on U.S. roadways. Most notably, Alphabet’s Waymo operates robotaxis in a variety of cities. Lucid is saying it plans to be the first for a consumer vehicle.
    Achieving such a system for Lucid will be daunting, especially given its track record on advanced driver assistance system, or ADAS.
    The company, by its own admission, has not lived up to its customers’ expectations. It has been slow to release systems capable of hands-free driving, like many companies offer, or compete with well-known “Level 2” technologies such as GM’s “Super Cruise” or Tesla’s “Autopilot” or “FSD.”
    Meanwhile, it’s set to be a record year for EV sales, but demand for all-electric cars is expected to decline with the end of federal incentives of up to $7,500.
    Lucid announced the self-driving technology plans as well as other initiatives in conjunction with the Nvidia GTC global artificial intelligence conference taking place this week in Washington, D.C. More

  • in

    ‘The problems are mounting daily:’ Air traffic controllers miss first paychecks in government shutdown

    Air traffic controllers are among the employees required to work during the shutdown even though they’re not receiving regular paychecks.
    Some controllers, which are already in short supply, are taking second jobs to make ends meet, union officials said.
    Transportation Secretary Sean Duffy said the shutdown is hurting government efforts to recruit and train air traffic controllers.

    A person rides an electric scooter past the air traffic control tower at Reagan Washington National Airport as the U.S. government shutdown continues in Arlington, Virginia, U.S., Oct. 8, 2025.
    Nathan Howard | Reuters

    U.S. air traffic controllers Tuesday missed their first full paychecks since the government shutdown began at the start of the month, while the Department of Transportation said flight delays due to staffing shortages have increased.
    The controllers are facing increased financial stress and it’s getting harder to recruit much-needed workers, union officials and Transportation Secretary Sean Duffy said Tuesday. Air traffic controllers and airport security screeners are among the employees required to work during the shutdown as essential employees, even though they’re not getting regular paychecks.

    “The problems are mounting daily,” said Nick Daniels, president of the National Air Traffic Controllers Association, at a news conference at New York’s LaGuardia Airport.
    The Federal Aviation Administration warned about staffing shortages at airports serving Philadelphia, Denver and airspace over a large swath of the Western U.S. that could disrupt flights on Tuesday.
    Duffy told reporters that 44% of the flight delays on Sunday, and about 24% of them on Monday, were due to air traffic controller staffing, compared with around 5% of the delays so far this year.

    U.S. Transportation Secretary Sean Duffy holds a press conference on the impact of the government shutdown on air travel, at LaGuardia Airport in the Queens borough of New York City, U.S., October 28, 2025.
    Shannon Stapleton | Reuters

    Duffy also said that the shutdown is hurting government air traffic training and recruiting, and that some funds for trainee stipends are “about to run out.”
    Air traffic controller union officials have said that some members have been driving for ride-hailing platforms and taking other jobs to make ends meet.

    Members of the union, including its president, plan to hand out leaflets and speak to the public at several airports across the U.S. on Tuesday, urging travelers to push Congress to end the shutdown.

    Read more CNBC airline news

    The government shutdown, entering its fourth week, has added to concerns about additional strain on the U.S. air traffic control system, which has challenged airlines and travelers alike because of years of understaffing.
    Flights earlier this month were delayed at several U.S. airports but the severe disruptions that preceded the end of the longest-ever shutdown, between late 2018 and early 2019, have not occurred. More